Issues of Veterinary Pharmaceutical Industry and IVP 2026
Pakistan’s veterinary pharmaceutical industry is currently facing various economic and management challenges, however, effective dialogue between the industry, experts and policymakers is essential to resolve these issues. For this purpose, the International Veterinary Pharmaceutical Expo 2026 (IVP 2026) is emerging as an important platform that will bring together all stakeholders of the sector in one place. These views were expressed by Dr. Asim Mahmood Khan, Chairman PVPA – Pakistan Veterinary Pharmaceuticals Association, in a special discussion.
AMK Group of Companies; Animal Health and Nutrition Solutions
Issues of the Veterinary Pharmaceutical Industry
He said that the annual market size of veterinary medicines in Pakistan has reached about Rs 90 to 100 billion, while the livestock sector contributes about 14 percent of GDP to the agricultural economy. Despite this great economic importance, the veterinary pharma industry is facing problems. These include import of raw materials, shortage of dollars and complex regulatory system, which is affecting the productivity of many local companies.
Veterinary Pharmaceutical Companies in Pakistan
He explained that more than 80 percent of the active pharmaceutical ingredients (API) used in the manufacture of veterinary drugs and vaccines in Pakistan are imported from abroad. In the past few years, due to the unavailability of dollars, banking restrictions and delays in the import process, shipments of raw materials from many companies remained stuck at ports. It badly affected the local production of drugs. He said that if this situation continues, the availability of essential drugs and vaccines for the treatment and prevention of diseases in livestock may also be affected.
Poultry Pharmaceutical Companies in Pakistan
Dr. Asim Mahmood Khan added that more than 200 veterinary drug manufacturing companies in Pakistan face lengthy registration, licensing and regulatory approval processes, which unnecessarily delays the introduction of new products into the market. In view of the risks of diseases spreading in livestock such as lumpy skin and foot-and-mouth disease, timely availability of veterinary drugs and vaccines is very important.
Livestock Pharmaceutical Companies in Pakistan
Significance of IVP 2026
He said that to solve these problems, the International Veterinary Pharmaceutical Expo 2026 is being organized by the Pakistan Veterinary Pharmaceuticals Association on April 28-29, 2026 in Lahore. This expo will provide a common platform for the veterinary pharma industry, livestock experts, policymakers, regulatory bodies and investors where the challenges facing the industry can be discussed openly.
Poultry Vaccine Companies and Suppliers in Pakistan
Dr. Asim Mahmood Khan Chairman PVPA said that the expo will showcase veterinary medicines, vaccines, feed additives, livestock technology and modern equipment, as well as scientific and policy sessions in which important topics such as promotion of local manufacturing, availability of raw materials, regulatory reforms and export prospects will be discussed.
Dairy and Livestock Vaccine Companies and Suppliers in Pakistan
Chairman PVPA Pakistan Veterinary Pharmaceuticals Association Dr. Asim Mahmood Khan said that the International Veterinary Pharmaceutical Expo 2026 is not just an exhibition but a platform where practical cooperation between the industry, government and experts can be promoted. He expressed the hope that through this event, workable solutions to the problems faced by the veterinary pharma industry will emerge and new avenues will be paved for the development of Pakistan’s livestock sector.
Pakistan Veterinary Pharmaceuticals Association (PVPA)
